<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-vaccines-08-00273">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Edelman</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ascher</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Oster</surname>
    <given-names>C.N.</given-names>
   </name>
   <name>
    <surname>Ramsburg</surname>
    <given-names>H.H.</given-names>
   </name>
   <name>
    <surname>Cole</surname>
    <given-names>F.E.</given-names>
   </name>
   <name>
    <surname>Eddy</surname>
    <given-names>G.A.</given-names>
   </name>
  </person-group>
  <article-title>Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84)</article-title>
  <source>J. Infect. Dis.</source>
  <year>1979</year>
  <volume>140</volume>
  <fpage>708</fpage>
  <lpage>715</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/140.5.708</pub-id>
  <pub-id pub-id-type="pmid">528788</pub-id>
 </element-citation>
</ref>
